Genetic polymorphisms and oral cancer

Journal of UOEH

Volumn 32, Issue 3, 2010, Pages 221-236

  Taniyama, Yukari ^a   Takeuchi, Shohei ^a   Kuroda, Yoshiki ^a  

^a UNIVERSITY OF MIYAZAKI   (Japan)

Author keywords

Cytochrome P450; Glutathione S transferase; N acetyltransferases; Oral cancer; TP53

Indexed keywords

ALDEHYDE DEHYDROGENASE; ARYLAMINE ACETYLTRANSFERASE; CYCLIN D1; CYTOCHROME P450; GLUTATHIONE TRANSFERASE; ISOENZYME; N ACETYLTRANSFERASE 1; N-ACETYLTRANSFERASE 1; PROTEIN P53;

DNA REPAIR; GENETIC POLYMORPHISM; GENETICS; HUMAN; MOUTH TUMOR; REVIEW;

ALDEHYDE DEHYDROGENASE; ARYLAMINE N-ACETYLTRANSFERASE; CYCLIN D1; CYTOCHROME P-450 ENZYME SYSTEM; DNA REPAIR; GLUTATHIONE TRANSFERASE; HUMANS; ISOENZYMES; MOUTH NEOPLASMS; POLYMORPHISM, GENETIC; TUMOR SUPPRESSOR PROTEIN P53;

EID: 78049503948     PISSN: 0387821X     EISSN: None     Source Type: Journal    
DOI: 10.7888/juoeh.32.221     Document Type: Article

References (89)

1. Kabat GC, Chang C.I & Wynder EL (1994): The role of tobacco, alcohol use, and body mass index in oral and pharyngeal cancer. Int J Epidemiol 23: 1137-1144
2. Maier H, De Vries N & Snow GB (1991): Occupational factors in the aetiology of head and neck cancer. Clin Otolaryngol Allied Sci 16: 406-412
3. Maier H, Dietz A, Gewelke U, Heller WD & Weidauer H (1992): Tobacco and alcohol and the risk of head and neck cancer. Clin Investig 70: 320-327
4. Ide R, Mizoue T, Fujino Y, Hoshiyama Y, Sakata K, Tamakoshi A & Yoshimura T (2008): Cigarette smoking, alcohol drinking, and oral and pharyngeal cancer mortality in Japan. Oral Dis 14: 314-319
5. Morse DE, Psoter WJ, Cleveland D, Cohen D, Mohit-Tabatabai M, Kosis DL & Eisenberg E (2007): Smoking and drinking in relation to oral cancer and oral epithelial dysplasia. Cancer Causes Control 18:919-929
6. Nebcrt DW, Nelson DR, Coon MJ et al (1991):The P450 superfamily: update on new sequences, gene mapping, and recommended nomenclature. DNA Cell Biol 10: 1-14
7. Nakajima T, Elovaara E, Anttila S, Hirvonen A, Camus AM, Hayes JD, Ketterer B & Vainio H (1995): Expression and polymorphism of glutathione S-transferase in human lungs: risk factors in smoking-rclated lung cancer. Carcinogenesis 16: 707-711
8. Kiyohara C, Hirohata T & Inutsuka S (1996): The relationship between aryl hydrocarbon hydroxylase and polymorphisms of the CYPlAl gene. Jpn J Cancer Res 87: 18-24
9. Spurr NK, Gough AC, Stevenson K & Wolf CR (1987): Msp-1 polymorphism detected with a cDNA probe for the P-450 I family on chromosome 15. Nucleic Acids Res 15: 5901
10. Hemminki K, Dickey C, Karlsson S, Bell D, Hsu Y, Tsai WY, Mooney LA, Savela K & Perera FP (1997): Aromatic DNA adducts in foundry workers in relation to exposure, life style and CYPlAl and glutathione transferase Ml genotype. Carcinogenesis 18: 345-350
11. Kawajiri K, Eguchi H, Nakachi K, Sekiya T & Yamamoto M (1996): Association of CYPlAl germ line polymorphisms with mutations of the p53 gene in lung cancer. Cancer Res 56: 72-76
12. Nimura Y, Yokoyama S, Fujimori M, Aoki T, Adachi W, Nasu T, He M, Ping YM & lida F (1997): Genotyping of the CYPlAl and GSTM1 genes in esophageal carcinoma patients with special reference to smoking. Cancer 80: 852-857
13. Tanimoto K, Hayashi S, Yoshiga K & Ichikawa T (1999): Polymorphisms of the CYPlAl and GSTM1 gene involved in oral squamous cell carcinoma in association with a cigarette dose. Oral Oncol 35: 191-196
14. Hashibe M, Brennan P, Strange RC et al (2003): Meta-and pooled analyses of GSTM1, GSTT1, GSTP1, and CYPlAl genotypes and risk of head and neck cancer. Cancer Epidemiol Biomarkers Prev 12:1509-1517
15. Nakachi K, Imai K, Hayashi S & Kawajiri K (1993): Polymorphisms of the CYPlAl and glutathione S-transferase genes associated with susceptibility to lung cancer in relation to cigarette dose in a Japanese population. Cancer Res 53: 2994-2999
16. Hirvonen A, Husgafvcl-Pursiainen K, Anttila S & Vainio H (1993): The GSTM1 null genotype as a potential risk modifier for squamous cell carcinoma of the lung. Carcinogenesis 14: 1479-1481
17. Oude Ophuis MB, van Lieshout EM, Roelofs HM, Peters WH & Manni JJ (1998): Glutathione S-transferase Ml and Tl and cytochrome P4501A1 polymorphisms in relation to the risk for benign and malignant head and neck lesions. Cancer 82: 936-943
18. Morita S, Yano M, Tsujinaka T et al (1999): Genetic polymorphisms of drug-metabolizing enzymes and susceptibility to head-and-neck squamous-cell carcinoma. Int J Cancer 80: 685-688
19. Hung HC, Chuang J, Chien YC, Chern HD, Chiang CP, Kuo YS, Hildesheim A & Chen CJ (1997): Genetic polymorphisms of CYP2E1, GSTM1, and GSTT1; environmental factors and risk of oral cancer. Cancer Epidemiol Biomarkers Prev 6: 901-905
20. Grant DM, Hughes NC, Janezic SA, Goodfcllow GH, Chen HJ, Gaedigk A, Yu VL & Grewal R (1997): Human acetyltransferase polymorphisms. Mutat Res 376: 61-70
21. Hirvonen A (1999): Polymorphic NATs and cancer predisposition. IARC Sci Publ 148: 251-270
22. Bell DA, Badawi AF, Lang NP, Ilett KF, Kadlubar FF & Hirvonen A (1995): Polymorphism in the N-acetyltransfcrase 1 (NAT1) polyadenylation signal: association of NAT 1*10 allele with higher N-acetylation activity in bladder and colon tissue. Cancer Res 55: 5226-5229
23. Lin H.T, Han CY, Lin BK & Hardy S (1993): Slow acetylator mutations in the human polymorphic N-acetyltransferase gene in 786 Asians, blacks, Hispanics, and whites: application to metabolic epidemiology. Am J Hum Genet 52: 827-834
24. Hickman D & Sim E (1991): N-acetyltransferase polymorphism. Comparison of phenotype and genotype in humans. Biochem Pharmacol 42: 1007-1014
25. Grant DM (1993): Molecular genetics of the N-acetyltransferases. Pharmacogenetics 3: 45-50
26. Fronhoffs S, Briining T, Ortiz-Pallardo E et al (2001): Real-time PCR analysis of the N-acetyltransferase NAT1 allele *3, *4, *10, *11, *14 and *17 polymorphism in squamous cell cancer of head and neck. Carcinogenesis 22: 1405-1412
27. Olshan AF, Weissler MC, Watson MA & Bell DA (2000): GSTM1, GSTT1, GSTP1, CYP1A1, and NAT1 polymorphisms, tobacco use, and the risk of head and neck cancer. Cancer Epidemiol Biomarkers Prev 9: 185-191
28. Henning S, Cascorbi I, Munchow B, Jahnke V & Roots I (1999): Association of arylamine N-acetyltransferases NAT1 and NAT2 genotypes to laryngeal cancer risk. Pharmacogenetics 9: 103-111
29. Katoh T, Kaneko S, Boissy R, Watson M, Ikemura K & Bell DA (1998): A pilot study testing the association between N-acetyltransferases 1 and 2 and risk of oral squamous cell carcinoma in Japanese people. Carcinogenesis 19: 1803-1807
30. Chen C, Ricks S, Doody DR, Fitzgibbons ED, Porter PL & Schwartz SM (2001): N-Acetyltransferase 2 polymorphisms, cigarette smoking and alcohol consumption, and oral squamous cell cancer risk. Carcinogenesis 22: 1993-1999
31. Zhong S, Wyllie AH, Barnes D, Wolf CR & Spurr NK (1993): Relationship between the GSTM1 genetic polymorphism and susceptibility to bladder, breast and colon cancer. Carcinogenesis 14: 1821-1824
32. Nazar-Stewart V, Motulsky AG, Eaton DL, White E, Hornung SK, Leng ZT, Stapleton P & Weiss NS (1993): The glutathione S-transferase m( polymorphism as a marker for susceptibility to lung carcinoma. Cancer Res 53: 2313-2318
33. Brockmöller J, Kerb R, Drakoulis N, Staffeldt B & Roots I (1994): Glutathione S-transferase Ml and its variants A and B as host factors of bladder cancer susceptibility: a case-control study. Cancer Res 54:4103-4111
34. Deakin M, Elder J, Hendrickse C et al (1996): Glutathione S-transferase GSTT1 genotypes and susceptibility to cancer: studies of interactions with GSTM1 in lung, oral, gastric and colorectal cancers. Carcinogenesis 17: 881-884
35. Brockmoller J, Cascorbi I, Kerb R & Roots I (1996): Combined analysis of inherited polymorphisms in arylamine N-acetyltransferase 2, glutathione S-transfcrases Ml and Tl, microsomal epoxide hydrolase, and cytochrome P450 enzymes as modulators of bladder cancer risk. Cancer Res 56: 3915-3925
36. Katoh T, Nagata N, Kuroda Y, Itoh 11, Kawahara A, Kuroki N, Ookuma R & Bell DA (1996): Glutathione S-transferase Ml (GSTM1) and Tl (GSTT1) genetic polymorphism and susceptibility to gastric and colorectal adenocarcinoma. Carcinogenesis 17: 1855-1859
37. Srcelekha XT, Ramadas K, Pandey M, Thomas G, Nalinakumari KR & Pillai MR (2001): Genetic polymorphism of CYP1 Al, GSTM1 and GSTT1 genes in Indian oral cancer. Oral Oncol 37: 593-598
38. Sato M, Sato T, Izumo T & Amagasa T (2000): Genetically high susceptibility to oral squamous cell carcinoma in terms of combined genotyping of CYP1A1 and GSTM1 genes. Oral Oncol 36: 267-271
39. Drummond SN, De Marco L, Noronha JC & Gomez RS (2004): GSTM1 polymorphism and oral squamous cell carcinoma. Oral Oncol 40: 52-55
40. Drummond SN, Gomez RS, Motta Noronha JC, Pordeus IA, Barbosa AA & De Marco L (2005): Association between GSTT-1 gene deletion and the susceptibility to oral squamous cell carcinoma in cigarette-smoking subjects. Oral Oncol 41: 515-519
41. Gcisler SA, Olshan AF, Cai.1, Weissler M, Smith J & Bell D (2005): Glutathione S-transferase polymorphisms and survival from head and neck cancer. Head Neck 27: 232-242
42. Anantharaman D, Chaubal PM, Kannan S, Bhisey RA & Mahimkar MB (2007): Susceptibility to oral cancer by genetic polymorphisms at CYP1A1, GSTM1 and GSTT1 loci among Indians: tobacco exposure as a risk modulator. Carcinogenesis 28: 1455-1462
43. Ali-Osman F, Akande O, Antoun G, Mao JX & Buolamwini J (1997): Molecular cloning, characterization, and expression in Eschcrichia coli of full-length cDNAs of three human glutathione S-transfcrase Pi gene variants. Evidence for differential catalytic activity of the encoded proteins. J Biol Chem 272: 10004-10012
44. Morita S, Yano M, Tsujinaka T, Ogawa A, Taniguchi M, Kaneko K, Shiozaki H, Doki Y, Inoue M & Mondcn M (1998): Association between genetic polymorphisms of glutathione S-transferase PI and N-acetyltransfcrase 2 and susceptibility to squamous-cell carcinoma of the esophagus. Int J Cancer 79:517-520
45. Harries LW, Stubbins MI Forman D, Howard GC & Wolf CR (1997): Identification of genetic polymorphisms at the glutathione S-transferase Pi locus and association with susceptibility to bladder, testicular and prostate cancer. Carcinogenesis 18: 641-644
46. Ryberg D, Skaug V, Hewer A, Phillips DH, Harries LW, Wolf CR, Ogreid D, Ulvik A, Vu P & Haugen A (1997): Genotypes of glutathione transferase Ml and PI and their significance for lung DNA adduct levels and cancer risk. Carcinogenesis 18: 1285-1289
47. Park JY, Schantz SP, Stern JC, Kaur T & Lazarus P (1999): Association between glutathione S-transferase pi genetic polymorphisms and oral cancer risk. Pharmacogenetics 9: 497-504
48. Katoh T, Kaneko S, Takasawa S, Nagata N, Inatomi H, Ikemura K, Itoh H, Matsumoto T, Kawamoto T & Bell DA (1999): Human glutathione S-transferase PI polymorphism and susceptibility to smoking related epithelial cancer; oral, lung, gastric, colorectal and urothelial cancer. Pharmacogenetics 9: 165-169
49. Blot WJ, McLaughlin JK, Winn DM, Austin DF, Greenberg RS, Preston-Martin S, Bernstein L, Schoenberg JB, Stemhagen A & Fraumeni JF Jr (1988): Smoking and drinking in relation to oral and pharyngcal cancer. Cancer Res 48: 3282-3287
50. Ristow H & Obe G (1978): Acetaldehyde induces cross-links in DNA and causes sister-chromatid exchanges in human cells. Mutat Res 58: 115-119
51. Dellarco VL (1988): A mutagenicity assessment of acetaldehyde. Mutat Res 195: 1-20
52. Albano E, Clot P, Comoglio A, Dianzani MU & Tomasi A (1994): Free radical activation of acetaldehyde and its role in protein alkylation. FEBS Lett 348: 65-69
53. Goedde HW, Agarwal DP, Fritze G et al (1992): Distribution of ADH2 and ALDH2 genotypes in different populations. Hum Genet 88: 344-346
54. Mizoi Y, Yamamoto K, Ueno Y, Fukunaga T & Harada S (1994): Involvement of genetic polymorphism of alcohol and aldehyde dehydrogenases in individual variation of alcohol metabolism. Alcohol Alcohol 29: 707-710
55. Chao YC, Wang MF, Tang HS, Hsu CT & Yin SJ (1994): Genotyping of alcohol dehydrogenase at the ADH2 and ADH3 loci by using a polymerase chain reaction and restriction-fragment-length polymorphism in Chinese alcoholic cirrhotics and non-alcoholics. Proc Natl Sci Counc Repub China B 18:101-106
56. Yokoyama A, Muramatsu T, Omori T, Yokoyama T, Matsushita S, Higuchi S, Maruyama K & Ishii H (2001): Alcohol and aldehyde dehydrogenase gene polymorphisms and oropharyngolaryngeal, esophageal and stomach cancers in Japanese alcoholics. Carcinogenesis 22: 433-439
57. Hashimoto T, Uchida K, Okayama N, Imate Y, Suehiro Y, Ueyama Y, Yamashita H & Hinoda Y (2006): ALDH2 1510 G/A (Gln487Lys) polymorphism interaction with age in head and neck squamous cell carcinoma. Tumour Biol 27: 334-338
58. Katoh T, Kaneko S, Kohshi K, Munaka M, Kitagawa K, Kunugita N, Ikemura K & Kawamoto T (1999): Genetic polymorphisms of tobacco-and alcohol-related metabolizing enzymes and oral cavity cancer. Int J Cancer 83: 606-609
59. Nomura T, Noma H, Shibahara T, Yokoyama A, Muramatusu T & Ohmori T (2000): Aldehyde dehydrogenase 2 and glutathione S-transferase M 1 polymorphisms in relation to the risk for oral cancer in Japanese drinkers. Oral Oncol 36: 42-46
60. Asakage T, Yokoyama A, Haneda T et al (2007): Genetic polymorphisms of alcohol and aldehyde dehydrogenases, and drinking, smoking and diet in Japanese men with oral and pharyngeal squamous cell carcinoma. Carcinogenesis 28: 865-874
61. Shen YC, Fan JH, Edenberg HJ et al (1997): Polymorphism of ADH and ALDH genes among four ethnic groups in China and effects upon the risk for alcoholism. Alcohol Clin Exp Res 21: 1272-1277
62. Harty LC, Caporaso NE, Hayes RB et al (1997): Alcohol dehydrogenase 3 genotype and risk of oral cavity and pharyngeal cancers. J Natl Cancer Inst 89: 1698-1705
63. Schwartz SM, Doody DR, Fitzgibbons ED, Ricks S, Porter PL & Chen C (2001): Oral squamous cell cancer risk in relation to alcohol consumption and alcohol dehydrogenase-3 genotypes. Cancer Epidemiol Biomarkers Prev 10: 1137-1144
64. Solomon PR, Selvam GS & Shanmugam G (2008): Polymorphism in ADH and MTHFR genes in oral squamous cell carcinoma of Indians. Oral Dis 14: 633-639
65. Roy B, Beamon J, Balint E & Reisman D (1994): Transactivation of the human p53 tumor suppressor gene by c-Myc/Max contributes to elevated mutant p53 expression in some tumors. Mol Cell Biol 14:7805-7815
66. Wcston A, Ling-Cawley HM, Caporaso NE, Bowman ED, Hoover RN, Tmmp BF & Harris CC (1994): Determination of the allelic frequencies of an L-myc and a p53 polymorphism in human lung cancer. Carcinogenesis 15: 583-587
67. Murata M, Tagawa M, Kimura M, Kimura H, Watanabe S & Saisho H (1996): Analysis of a germ line polymorphism of the p53 gene in lung cancer patients; discrete results with smoking history. Carcinogenesis 17: 261-264
68. Kawajiri K, Nakachi K, Imai K, Watanabe J & Hayashi S (1993): Germ line polymorphisms of p53 and CYP1A1 genes involved in human lung cancer. Carcinogenesis 14: 1085-1089
69. Wang YC, Chen CY, Chen SK, Chang YY & Ein P (1999): p53 codon 72 polymorphism in Taiwanese lung cancer patients: association with lung cancer susceptibility and prognosis. Clin Cancer Res 5: 129-134
70. Storey A, Thomas M, Kalita A, Harwood C, Gardiol D, Mantovani F, Breuer J, Leigh IM, Matlashewski G & Banks L (1998): Role of a p53 polymorphism in the development of human papillomavirus-associated cancer. Nature 393: 229-234
71. Tandlc AT, Sanghvi V & Saranath D (2001): Determination of p53 genotypes in oral cancer patients from India. Br J Cancer 84: 739-742
72. Kuroda Y, Nakao H, Ikemura K & Katoh T (2007): Association between the TP53 codon72 polymorphism and oral cancer risk and prognosis. Oral Oncol 43: 1043-1048
73. Thompson LH (1996): Evidence that mammalian cells possess homologous recombinational repair pathways. Mutat Res 363: 77-88
74. Hansen RD, Sørenscn M, Tjønneland A, Overvad K, Wallin H, Raaschou-Nielsen O & Vogel U (2007): XPAA23G, XPC Lys939Gln, XPD Lys751Gln and XPD Asp312Asn polymorphisms, interactions with smoking, alcohol and dietary factors, and risk of colorectal cancer. Mutat Res 619: 68-80
75. Masson M, Niedergang C, Schreiber V, Muller S, Menissier-de Murcia J & de Murcia G (1998): XRCCl is specifically associated with poly (ADP-ribose) polymerase and negatively regulates its activity following DNA damage. Mol Cell Biol 18: 3563-3571
76. Lunn RM, Langlois RG, Hsieh LL, Thompson CL & Bell DA (1999): XRCCl polymorphisms: effects on af latoxin B1-DNA adducts and glycophorin A variant frequency. Cancer Res 59: 2557-2561
77. Duell EJ, Millikan RC, Pittman GS, Winkcl S, Lunn RM, Tse CK, Eaton A, Mohrcnweiscr HW, Newman B & Bell DA (2001): Polymorphisms in the DNA repair gene XRCCl and breast cancer. Cancer Epidemiol Biomarkers Prev 10: 217-222
78. Sturgis EM, Castillo EJ, Li L, Zheng R, Eicher SA, dayman GL, Strom SS, Spitz MR & Wei Q (1999): Polymorphisms of DNA repair gene XRCCl in squamous cell carcinoma of the head and neck. Carcinogenesis 20: 2125-2129
79. Tae K, Lee HS, Park BJ, Park CW, Kim KR, Cho HY, Kim LH, Park BL & Shin HD (2004): Association of DNA repair gene XRCCl polymorphisms with head and neck cancer in Korean population. Int J Cancer 111: 805-808
80. Huang WY, Olshan AF, Schwartz SM, Berndt SI, Chen C, Llaca V, Chanock SJ, Fraumeni IF. Jr & Hayes RB (2005): Selected genetic polymorphisms in MGMT, XRCCl, XPD and XRCC3 and risk of head and neck cancer: a pooled analysis. Cancer Epidemiol Biomarkers Prev 14: 1747-1753
81. Sherr CJ (1996): Cancer cell cycles. Science 274: 1672-1677
82. Sherr CJ (1995): D-typecyclins. Trends Biochem Sci 20: 187-190
83. Nakahara Y, Shintani S, Mihara M, Kiyota A, Ueyama Y & Matsumura T (2000): Alterations of Rb, pl6 (INK4A) and cyclin Dl in the tumorigenesis of oral squamous cell carcinomas. Cancer Lett 160: 3-8
84. Toyoda H, Nakamura T, Shinoda M, Suzuki T, Hatooka S, Kobayashi S, Ohashi K, Seto M, Shiku H & Nakamura S (2000): Cyclin Dl expression is useful as a prognostic indicator for advanced esophageal carcinomas, but not for superficial tumors. Dig Dis Sci 45: 864-869
85. Keum JS, Kong G, Yang SC, Shin DH, Park SS, Lee JH & Lee JD (1999): Cyclin Dl overexpression is an indicator of poor prognosis in resectable non-small cell lung cancer. Br J Cancer 81: 127-132
86. Zheng Y, Shen H, Sturgis EM, Wang LE, Eicher SA, Strom SS, Frazier ML, Spitz MR & Wei Q (2001): Cyclin Dl polymorphism and risk for squamous cell carcinoma of the head and neck: a case-control study. Carcinogenesis 22: 1195-1199
87. Matthias C, Branigan K, Jahnke V, Leder K, Haas J, Heighway J, Jones PW, Strange RC, Fryer AA & Hoban PR (1998): Polymorphism within the cyclin Dl gene is associated with prognosis in patients with squamous cell carcinoma of the head and neck. Clin Cancer Res 4: 2411-2418
88. Huang M, Spitz MR, Gu J, Lee JJ, Lin J, Lippman SM & Wu X (2006): Cyclin Dl gene polymorphism as a risk factor for oral premalignant lesions. Carcinogenesis 27: 2034-2037
89. Holley SL, Matthias C, Jahnke V, Fryer AA, Strange RC & Hoban PR (2005): Association of cyclin Dl polymorphism with increased susceptibility to oral squamous cell carcinoma. Oral Oncol 41: 156-160